Viewing Study NCT00077350


Ignite Creation Date: 2025-12-24 @ 4:45 PM
Ignite Modification Date: 2025-12-27 @ 7:56 AM
Study NCT ID: NCT00077350
Status: COMPLETED
Last Update Posted: 2013-02-27
First Post: 2004-02-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Trial of Triapine (NSC #663249) in Combination With Gemcitabine as Second Line Treatment of Non-Small Cell Lung Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module